Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

1. Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

   RECRUITING → SUSPENDED

   Recorded 2026-10-16

   View record

2. Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

   NOT YET RECRUITING → RECRUITING

   Recorded 2026-10-16

   View record

3. The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

   COMPLETED → TERMINATED

   Recorded 2026-10-11

   View record